Inhalation Anesthesia Market by Product (Sevoflurane, Desflurane, Isoflurane, and Nitrous Oxide), Application (Induction and Maintenance), and End-User (Hospitals and Ambulatory Surgical Centers): Global Opportunity Analysis and Industry Forecast, 2019–2026
The global inhalation anesthesia market was valued at $1,137 million in 2018 and is expected to reach $1,549 million by 2026, registering a CAGR of 4.2% from 2019 to 2026. Inhalation anesthetics are primarily used during surgical procedures to control pain, blood pressure, blood flow, and heart rate & rhythm of a patient. Further, inhalational anesthesia is primarily used for induction of general anesthesia and sedation purposes. The most widely used inhalational anesthetics are sevoflurane, desflurane, and nitrous oxide. Inhalational anesthetics usually result inrespiratory depression, reduction in arterial blood pressure and cerebral metabolic demand, and rise in cerebral blood flow. The most common side effect of inhalation anesthesia is nausea.
Significant rise in the number of emergency incidences and road accidents; surge in prevalence of various disorders such as cancer, respiratory diseases, and gastrointestinal disorders; upsurge in number of surgical procedures; and increased use of these in various disease diagnosis drive the inhalation anesthesia market growth. In addition, factors such as innovations in these devices and governmental support regarding the use of inhalation anesthetics further fuel the market growth. However, risks associated with certain therapeutic and diagnostic devices for neonates and low adoption rate of new technologies, owing to reluctance from physicians for treatment, restrain the growth of the respiratory care devices market. In addition, environmental concerns regarding vigorous usage of inhalation anesthesia is anticipated to hamper the market growth. Moreover, significant rise in elderly population and increase in healthcare expenditures in developing economies are anticipated to provide lucrative growth opportunities for the market.
The market is segmented on the basis of product, application, end user, and region. By product it is segmented into sevoflurane, desflurane, isoflurane, and nitrous oxide. On the basis of application, it is bifurcated into induction and maintenance. By end user it is classified into hospitals and ambulatory surgical centers. Region wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
KEY BENEFITS FOR STAKEHOLDERS
By Product
Significant rise in the number of emergency incidences and road accidents; surge in prevalence of various disorders such as cancer, respiratory diseases, and gastrointestinal disorders; upsurge in number of surgical procedures; and increased use of these in various disease diagnosis drive the inhalation anesthesia market growth. In addition, factors such as innovations in these devices and governmental support regarding the use of inhalation anesthetics further fuel the market growth. However, risks associated with certain therapeutic and diagnostic devices for neonates and low adoption rate of new technologies, owing to reluctance from physicians for treatment, restrain the growth of the respiratory care devices market. In addition, environmental concerns regarding vigorous usage of inhalation anesthesia is anticipated to hamper the market growth. Moreover, significant rise in elderly population and increase in healthcare expenditures in developing economies are anticipated to provide lucrative growth opportunities for the market.
The market is segmented on the basis of product, application, end user, and region. By product it is segmented into sevoflurane, desflurane, isoflurane, and nitrous oxide. On the basis of application, it is bifurcated into induction and maintenance. By end user it is classified into hospitals and ambulatory surgical centers. Region wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
KEY BENEFITS FOR STAKEHOLDERS
- The study provides an in-depth analysis of the market along with the current trends and future estimations to elucidate the imminent investment pockets.
- It offers a quantitative analysis from 2018 to 2026, which is expected to enable the stakeholders to capitalize on prevailing market opportunities.
- Comprehensive analysis of all geographical regions is provided to determine the prevailing opportunities.
- Key players are profiled, and their strategies are analyzed thoroughly to understand the competitive outlook of the global market.
By Product
- Sevoflurane
- Desflurane
- Isoflurane
- Nitrous Oxide
- Induction
- Maintenance
- Hospitals
- Ambulatory Surgical Centers
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
- Asia Pacific
- Japan
- China
- India
- Rest of Asia-Pacific
- LAMEA
- Brazil
- Saudi Arabia
- South Africa
- Rest of LAMEA
- AbbVie Inc.
- Baxter International Inc.
- Fresenius SE & Co.
- Halocarbon Products Corporation
- Hikma Pharmaceuticals PLC
- Jiangsu Hengrui Medicine Co., Ltd
- Lunan Pharmaceutical Group Co. Ltd
- Novartis AG
- Piramal Enterprises Ltd
- Troikaa Pharmaceuticals Ltd
CHAPTER 1: INTRODUCTION
1.1. Report description
1.2. Key benefits for stakeholders
1.3. Key market segments
1.4. Research methodology
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst Tools and Models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. Key findings of the study
2.2. CXO perspective
CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top investment pockets
3.3. Porter’s five forces analysis
3.3.1. Moderate bargaining power of buyers
3.3.2. Low bargaining power of suppliers
3.3.3. Moderate threat of substitutes
3.3.4. Low threat of new entrants
3.3.5. Moderate competitive rivalry
3.4. Top player positioning
3.5. Market dynamics
3.5.1. Drivers
3.5.1.1. Increase in number of surgeries
3.5.1.2. Surge in severe road accidents
3.5.2. Restraint
3.5.2.1. Stringent regulatory scenario
3.5.3. Opportunity
3.5.3.1. Growth opportunities in emerging economies
CHAPTER 4: INHALATION ANESTHESIA MARKET, BY PRODUCT
4.1. Overview
4.1.1. Market size and forecast
4.2. Sevoflurane
4.2.2. Key market trends and opportunities
4.2.3. Market size and forecast
4.2.4. Market share analysis, by country
4.3. Desflurane
4.3.1. Key market trends and growth opportunities
4.3.2. Market size and forecast
4.3.3. Market share analysis, by country
4.4. Isoflurane
4.4.1. Key market trends and opportunities
4.4.2. Market size and forecast
4.4.3. Market share analysis, by country
4.5. Nitrous Oxide
4.5.1. Key market trends and opportunities
4.5.2. Market size and forecast
4.5.3. Market share analysis, by country
CHAPTER 5: INHALATION ANESTHESIA MARKET, BY APPLICATION
5.1. Overview
5.1.1. Market size and forecast
5.2. Induction
5.2.1. Market size and forecast
5.2.2. Market share analysis, by country
5.3. Maintenance
5.3.1. Market size and forecast
5.3.2. Market share analysis, by country
CHAPTER 6: INHALATION ANESTHESIA MARKET, BY END USER
6.1. Overview
6.1.1. Market size and forecast
6.2. Hospitals
6.2.1. Market size and forecast
6.2.2. Market share analysis, by country
6.3. Ambulatory service centers
6.3.1. Market size and forecast
6.3.2. Market share analysis, by country
CHAPTER 7: INHALATION ANESTHESIA MARKET, BY REGION
7.1. Overview
7.1.1. Market size and forecast
7.2. North America
7.2.1. Key market trends and opportunities
7.2.2. Market size and forecast, by country
7.2.3. North America market size and forecast, by product
7.2.4. North America Market size and forecast, by application
7.2.5. North America market size and forecast, by end user
7.2.5.1. U.S. market size and forecast, by product
7.2.5.2. U.S. market size and forecast, by application
7.2.5.3. U.S. market size and forecast, by end user
7.2.5.4. Canada market size and forecast, by product
7.2.5.5. Canada market size and forecast, by application
7.2.5.6. Canada market size and forecast, by end user
7.2.5.8. Mexico market size and forecast, by product
7.2.5.9. Mexico market size and forecast, by application
7.2.5.10. Mexico market size and forecast, by end user
7.3. Europe
7.3.1. Key growth factors and opportunities
7.3.2. Market size and forecast, by country
7.3.3. Europe market size and forecast, by product
7.3.4. Europe Market size and forecast, by application
7.3.5. Europe market size and forecast, by end user
7.3.5.1. Germany market size and forecast, by product
7.3.5.2. Germany market size and forecast, by application
7.3.5.3. Germany market size and forecast, by end user
7.3.5.4. France market size and forecast, by product
7.3.5.5. France market size and forecast, by application
7.3.5.6. France market size and forecast, by end user
7.3.5.7. UK market size and forecast, by product
7.3.5.8. UK market size and forecast, by application
7.3.5.9. UK market size and forecast, by end user
7.3.5.10. Italy market size and forecast, by product
7.3.5.11. Italy market size and forecast, by application
7.3.5.12. Italy market size and forecast, by end user
7.3.5.13. Spain market size and forecast, by product
7.3.5.14. Spain market size and forecast, by application
7.3.5.15. Spain market size and forecast, by end user
7.3.5.17. Rest of Europe market size and forecast, by product
7.3.5.18. Rest of Europe market size and forecast, by application
7.3.5.19. Rest of Europe market size and forecast, by end user
7.4. Asia-Pacific
7.4.1. Key growth factors and opportunities.
7.4.2. Asia-Pacific market size and forecast, by country
7.4.3. Asia-Pacific market size and forecast, by product
7.4.4. Asia-Pacific market size and forecast, by application
7.4.5. Asia-Pacific market size and forecast, by end user
7.4.6.1. Japan market size and forecast, by product
7.4.6.2. Japan market size and forecast, by application
7.4.6.3. Japan market size and forecast, by end user
7.4.6.4. China market size and forecast, by product
7.4.6.5. China market size and forecast, by application
7.4.6.6. China market size and forecast, by end user
7.4.6.8. India market size and forecast, by product
7.4.6.9. India market size and forecast, by application
7.4.6.10. India market size and forecast, by end user
7.4.6.11. Australia market size and forecast by product
7.4.6.12. Australia market size and forecast, by application
7.4.6.13. Australia market size and forecast, by end user
7.4.6.14. Rest of Asia-Pacific market size and forecast by product
7.4.6.15. Rest of Asia-Pacific market size and forecast, by application
7.4.6.16. Rest of Asia-Pacific market size and forecast, by end user
7.5. LAMEA
7.5.1. Key growth factors and opportunities
7.5.2. LAMEA market size and forecast, by country
7.5.3. LAMEA market size and forecast, by product
7.5.4. LAMEA market size and forecast, by application
7.5.5. LAMEA market size and forecast, by end user
7.5.5.1. Brazil market size and forecast, by product
7.5.5.2. Brazil market size and forecast, by application
7.5.5.3. Brazil market size and forecast, by end user
7.5.5.4. Saudi Arabia market size and forecast, by product
7.5.5.5. Saudi Arabia market size and forecast, by application
7.5.5.6. Saudi Arabia market size and forecast, by end user
7.5.5.7. South Africa market size and forecast, by product
7.5.5.8. South Africa market size and forecast, by application
7.5.5.9. South Africa market size and forecast, by end user
7.5.5.10. Rest of LAMEA market size and forecast, by product
7.5.5.11. Rest of LAMEA market size and forecast, by application
7.5.5.12. Rest of LAMEA market size and forecast, by end user
CHAPTER 8: COMPANY PROFILES
8.1. ABBVIE INC.
8.1.1. Company overview
8.1.2. Company snapshot
8.1.3. Operating business segment
8.1.4. Product portfolio
8.1.5. Business performance
8.2. BAXTER INTERNATIONAL INC.
8.2.1. Company overview
8.2.2. Company snapshot
8.2.3. Operating business segments
8.2.4. Product Portfolio
8.2.5. Business performance
8.3. Fresenius SE & Co. KGaA
8.3.1. Company overview
8.3.2. Company snapshot
8.3.3. Operating business segments
8.3.4. Product portfolio
8.3.5. Business performance
8.4. Halocarbon Products Corporation.
8.4.1. Company overview
8.4.2. Company snapshot
8.4.3. Operating business segments
8.4.4. Product portfolio
8.5. Hikma Pharmaceuticals PLC
8.5.1. Company overview
8.5.2. Company snapshot
8.5.3. Operating business segments
8.5.4. Product portfolio
8.5.5. Business performance
8.6. Jiangsu Hengrui Medicine Co., Ltd.
8.6.1. Company overview
8.6.2. Operating business segments
8.6.3. Product portfolio
8.7. Lunan Pharmaceutical Group Co. Ltd.
8.7.1. Company overview
8.7.2. Company snapshot
8.7.3. Operating business segments
8.7.4. Product portfolio
8.8. Novartis AG.
8.8.1. Company overview
8.8.2. Operating business segments
8.8.3. Product portfolio
8.8.4. Business performance
8.8.5. Key strategic moves and developments
8.9. Piramal Enterprises Ltd.
8.9.1. Company overview
8.9.2. Company snapshot
8.9.3. Operating business segments
8.9.4. Product portfolio
8.9.5. Business performance
8.10. Troikaa Pharmaceuticals, Ltd.
8.10.1. Company overview
8.10.2. Company snapshot
8.10.3. Operating business segments
8.10.4. Product portfolio
1.1. Report description
1.2. Key benefits for stakeholders
1.3. Key market segments
1.4. Research methodology
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst Tools and Models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. Key findings of the study
2.2. CXO perspective
CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top investment pockets
3.3. Porter’s five forces analysis
3.3.1. Moderate bargaining power of buyers
3.3.2. Low bargaining power of suppliers
3.3.3. Moderate threat of substitutes
3.3.4. Low threat of new entrants
3.3.5. Moderate competitive rivalry
3.4. Top player positioning
3.5. Market dynamics
3.5.1. Drivers
3.5.1.1. Increase in number of surgeries
3.5.1.2. Surge in severe road accidents
3.5.2. Restraint
3.5.2.1. Stringent regulatory scenario
3.5.3. Opportunity
3.5.3.1. Growth opportunities in emerging economies
CHAPTER 4: INHALATION ANESTHESIA MARKET, BY PRODUCT
4.1. Overview
4.1.1. Market size and forecast
4.2. Sevoflurane
4.2.2. Key market trends and opportunities
4.2.3. Market size and forecast
4.2.4. Market share analysis, by country
4.3. Desflurane
4.3.1. Key market trends and growth opportunities
4.3.2. Market size and forecast
4.3.3. Market share analysis, by country
4.4. Isoflurane
4.4.1. Key market trends and opportunities
4.4.2. Market size and forecast
4.4.3. Market share analysis, by country
4.5. Nitrous Oxide
4.5.1. Key market trends and opportunities
4.5.2. Market size and forecast
4.5.3. Market share analysis, by country
CHAPTER 5: INHALATION ANESTHESIA MARKET, BY APPLICATION
5.1. Overview
5.1.1. Market size and forecast
5.2. Induction
5.2.1. Market size and forecast
5.2.2. Market share analysis, by country
5.3. Maintenance
5.3.1. Market size and forecast
5.3.2. Market share analysis, by country
CHAPTER 6: INHALATION ANESTHESIA MARKET, BY END USER
6.1. Overview
6.1.1. Market size and forecast
6.2. Hospitals
6.2.1. Market size and forecast
6.2.2. Market share analysis, by country
6.3. Ambulatory service centers
6.3.1. Market size and forecast
6.3.2. Market share analysis, by country
CHAPTER 7: INHALATION ANESTHESIA MARKET, BY REGION
7.1. Overview
7.1.1. Market size and forecast
7.2. North America
7.2.1. Key market trends and opportunities
7.2.2. Market size and forecast, by country
7.2.3. North America market size and forecast, by product
7.2.4. North America Market size and forecast, by application
7.2.5. North America market size and forecast, by end user
7.2.5.1. U.S. market size and forecast, by product
7.2.5.2. U.S. market size and forecast, by application
7.2.5.3. U.S. market size and forecast, by end user
7.2.5.4. Canada market size and forecast, by product
7.2.5.5. Canada market size and forecast, by application
7.2.5.6. Canada market size and forecast, by end user
7.2.5.8. Mexico market size and forecast, by product
7.2.5.9. Mexico market size and forecast, by application
7.2.5.10. Mexico market size and forecast, by end user
7.3. Europe
7.3.1. Key growth factors and opportunities
7.3.2. Market size and forecast, by country
7.3.3. Europe market size and forecast, by product
7.3.4. Europe Market size and forecast, by application
7.3.5. Europe market size and forecast, by end user
7.3.5.1. Germany market size and forecast, by product
7.3.5.2. Germany market size and forecast, by application
7.3.5.3. Germany market size and forecast, by end user
7.3.5.4. France market size and forecast, by product
7.3.5.5. France market size and forecast, by application
7.3.5.6. France market size and forecast, by end user
7.3.5.7. UK market size and forecast, by product
7.3.5.8. UK market size and forecast, by application
7.3.5.9. UK market size and forecast, by end user
7.3.5.10. Italy market size and forecast, by product
7.3.5.11. Italy market size and forecast, by application
7.3.5.12. Italy market size and forecast, by end user
7.3.5.13. Spain market size and forecast, by product
7.3.5.14. Spain market size and forecast, by application
7.3.5.15. Spain market size and forecast, by end user
7.3.5.17. Rest of Europe market size and forecast, by product
7.3.5.18. Rest of Europe market size and forecast, by application
7.3.5.19. Rest of Europe market size and forecast, by end user
7.4. Asia-Pacific
7.4.1. Key growth factors and opportunities.
7.4.2. Asia-Pacific market size and forecast, by country
7.4.3. Asia-Pacific market size and forecast, by product
7.4.4. Asia-Pacific market size and forecast, by application
7.4.5. Asia-Pacific market size and forecast, by end user
7.4.6.1. Japan market size and forecast, by product
7.4.6.2. Japan market size and forecast, by application
7.4.6.3. Japan market size and forecast, by end user
7.4.6.4. China market size and forecast, by product
7.4.6.5. China market size and forecast, by application
7.4.6.6. China market size and forecast, by end user
7.4.6.8. India market size and forecast, by product
7.4.6.9. India market size and forecast, by application
7.4.6.10. India market size and forecast, by end user
7.4.6.11. Australia market size and forecast by product
7.4.6.12. Australia market size and forecast, by application
7.4.6.13. Australia market size and forecast, by end user
7.4.6.14. Rest of Asia-Pacific market size and forecast by product
7.4.6.15. Rest of Asia-Pacific market size and forecast, by application
7.4.6.16. Rest of Asia-Pacific market size and forecast, by end user
7.5. LAMEA
7.5.1. Key growth factors and opportunities
7.5.2. LAMEA market size and forecast, by country
7.5.3. LAMEA market size and forecast, by product
7.5.4. LAMEA market size and forecast, by application
7.5.5. LAMEA market size and forecast, by end user
7.5.5.1. Brazil market size and forecast, by product
7.5.5.2. Brazil market size and forecast, by application
7.5.5.3. Brazil market size and forecast, by end user
7.5.5.4. Saudi Arabia market size and forecast, by product
7.5.5.5. Saudi Arabia market size and forecast, by application
7.5.5.6. Saudi Arabia market size and forecast, by end user
7.5.5.7. South Africa market size and forecast, by product
7.5.5.8. South Africa market size and forecast, by application
7.5.5.9. South Africa market size and forecast, by end user
7.5.5.10. Rest of LAMEA market size and forecast, by product
7.5.5.11. Rest of LAMEA market size and forecast, by application
7.5.5.12. Rest of LAMEA market size and forecast, by end user
CHAPTER 8: COMPANY PROFILES
8.1. ABBVIE INC.
8.1.1. Company overview
8.1.2. Company snapshot
8.1.3. Operating business segment
8.1.4. Product portfolio
8.1.5. Business performance
8.2. BAXTER INTERNATIONAL INC.
8.2.1. Company overview
8.2.2. Company snapshot
8.2.3. Operating business segments
8.2.4. Product Portfolio
8.2.5. Business performance
8.3. Fresenius SE & Co. KGaA
8.3.1. Company overview
8.3.2. Company snapshot
8.3.3. Operating business segments
8.3.4. Product portfolio
8.3.5. Business performance
8.4. Halocarbon Products Corporation.
8.4.1. Company overview
8.4.2. Company snapshot
8.4.3. Operating business segments
8.4.4. Product portfolio
8.5. Hikma Pharmaceuticals PLC
8.5.1. Company overview
8.5.2. Company snapshot
8.5.3. Operating business segments
8.5.4. Product portfolio
8.5.5. Business performance
8.6. Jiangsu Hengrui Medicine Co., Ltd.
8.6.1. Company overview
8.6.2. Operating business segments
8.6.3. Product portfolio
8.7. Lunan Pharmaceutical Group Co. Ltd.
8.7.1. Company overview
8.7.2. Company snapshot
8.7.3. Operating business segments
8.7.4. Product portfolio
8.8. Novartis AG.
8.8.1. Company overview
8.8.2. Operating business segments
8.8.3. Product portfolio
8.8.4. Business performance
8.8.5. Key strategic moves and developments
8.9. Piramal Enterprises Ltd.
8.9.1. Company overview
8.9.2. Company snapshot
8.9.3. Operating business segments
8.9.4. Product portfolio
8.9.5. Business performance
8.10. Troikaa Pharmaceuticals, Ltd.
8.10.1. Company overview
8.10.2. Company snapshot
8.10.3. Operating business segments
8.10.4. Product portfolio
LIST OF TABLES
TABLE 01. INHALATION ANESTHESIA MARKET, BY PRODUCT, 2018–2026 ($MILLION)
TABLE 02. INHALATION ANESTHESIA MARKET FOR SEVOFLURANE, BY REGION, 2018–2026 ($MILLION)
TABLE 03. INHALATION ANESTHESIA MARKET FOR DESFLURANE, BY REGION, 2018–2026 ($MILLION)
TABLE 04. INHALATION ANESTHESIA MARKET FOR ISOFLURANE, BY REGION, 2018–2026 ($MILLION)
TABLE 05. INHALATION ANESTHESIA MARKET FOR NITROUS OXIDE, BY REGION, 2018–2026 ($MILLION)
TABLE 06. INHALATION ANESTHESIA MARKET, BY APPLICATION, 2018–2026 ($MILLION)
TABLE 07. INHALATION ANESTHESIA MARKET FOR INDUCTION, BY REGION, 2018–2026 ($MILLION)
TABLE 08. INHALATION ANESTHESIA FOR MAINTENANCES MARKET, BY REGION, 2018–2026 ($MILLION)
TABLE 09. INHALATION ANESTHESIA MARKET, BY END USER, 2018–2026 ($MILLION)
TABLE 10. INHALATION ANESTHESIA MARKET FOR HOSPITALS, BY REGION, 2018–2026 ($MILLION)
TABLE 11. INHALATION ANESTHESIA MAINTENANCES MARKET FOR AMBULATORY SERVICE CENTERS, BY REGION, 2018–2026 ($MILLION)
TABLE 12. INHALATION ANESTHESIA MARKET, BY REGION, 2018–2026 ($MILLION)
TABLE 13. NORTH AMERICA INHALATION ANESTHESIA MARKET, BY COUNTRY, 2018–2026 ($MILLION)
TABLE 14. NORTH AMERICA INHALATION ANESTHESIA MARKET, BY PRODUCT, 2018–2026 ($MILLION)
TABLE 15. NORTH AMERICA INHALATION ANESTHESIA MARKET, BY APPLICATION, 2018–2026 ($MILLION)
TABLE 16. NORTH AMERICA INHALATION ANESTHESIA MARKET, BY END USER, 2018–2026 ($MILLION)
TABLE 17. U.S. INHALATION ANESTHESIA MARKET BY PRODUCT, 2018–2026 ($MILLION)
TABLE 18. U.S. INHALATION ANESTHESIA MARKET BY APPLICATION, 2018–2026 ($MILLION)
TABLE 19. U.S. INHALATION ANESTHESIA MARKET BY END USER, 2018–2026 ($MILLION)
TABLE 20. CANADA INHALATION ANESTHESIA MARKET BY PRODUCT, 2018–2026 ($MILLION)
TABLE 21. CANADA INHALATION ANESTHESIA MARKET BY APPLICATION, 2018–2026 ($MILLION)
TABLE 22. CANADA INHALATION ANESTHESIA MARKET BY END USER, 2018–2026 ($MILLION)
TABLE 23. MEXICO INHALATION ANESTHESIA MARKET, BY PRODUCT, 2018–2026 ($MILLION)
TABLE 24. MEXICO INHALATION ANESTHESIA MARKET, BY APPLICATION, 2018–2026 ($MILLION)
TABLE 25. MEXICO INHALATION ANESTHESIA MARKET, BY END USER, 2018–2026 ($MILLION)
TABLE 26. EUROPE INHALATION ANESTHESIA MARKET, BY COUNTRY, 2018–2026 ($MILLION)
TABLE 27. EUROPE INHALATION ANESTHESIA MARKET, BY PRODUCT, 2018–2026 ($MILLION)
TABLE 28. EUROPE INHALATION ANESTHESIA MARKET, BY APPLICATION, 2018–2026 ($MILLION)
TABLE 29. EUROPE INHALATION ANESTHESIA MARKET, BY END USER, 2018–2026 ($MILLION)
TABLE 30. GERMANY INHALATION ANESTHESIA MARKET, BY PRODUCT, 2018–2026 ($MILLION)
TABLE 31. GERMANY INHALATION ANESTHESIA MARKET, BY APPLICATION, 2018–2026 ($MILLION)
TABLE 32. GERMANY INHALATION ANESTHESIA MARKET, BY END USER, 2018–2026 ($MILLION)
TABLE 33. FRANCE INHALATION ANESTHESIA MARKET, BY PRODUCT, 2018–2026 ($MILLION)
TABLE 34. FRANCE INHALATION ANESTHESIA MARKET, BY APPLICATION, 2018–2026 ($MILLION)
TABLE 35. FRANCE INHALATION ANESTHESIA MARKET, BY END USER, 2018–2026 ($MILLION)
TABLE 36. U.K. INHALATION ANESTHESIA MARKET, BY PRODUCT, 2018–2026 ($MILLION)
TABLE 37. U.K. INHALATION ANESTHESIA MARKET, BY APPLICATION, 2018–2026 ($MILLION)
TABLE 38. U.K. INHALATION ANESTHESIA MARKET, BY END USER, 2018–2026 ($MILLION)
TABLE 39. ITALY INHALATION ANESTHESIA MARKET, BY PRODUCT, 2018–2026 ($MILLION)
TABLE 40. ITALY INHALATION ANESTHESIA MARKET, BY APPLICATION, 2018–2026 ($MILLION)
TABLE 41. ITALY INHALATION ANESTHESIA MARKET, BY END USER, 2018–2026 ($MILLION)
TABLE 42. SPAIN INHALATION ANESTHESIA MARKET, BY PRODUCT, 2018–2026 ($MILLION)
TABLE 43. SPAIN INHALATION ANESTHESIA MARKET, BY APPLICATION, 2018–2026 ($MILLION)
TABLE 44. SPAIN INHALATION ANESTHESIA MARKET, BY END USER, 2018–2026 ($MILLION)
TABLE 45. REST OF EUROPE INHALATION ANESTHESIA MARKET, BY PRODUCT, 2018–2026 ($MILLION)
TABLE 46. REST OF EUROPE INHALATION ANESTHESIA MARKET, BY APPLICATION, 2018–2026 ($MILLION)
TABLE 47. REST OF EUROPE INHALATION ANESTHESIA MARKET, BY END USER, 2018–2026 ($MILLION)
TABLE 48. ASIA-PACIFIC INHALATION ANESTHESIA MARKET, BY COUNTRY, 2018–2026 ($MILLION)
TABLE 49. ASIA-PACIFIC INHALATION ANESTHESIA MARKET, BY PRODUCT, 2018–2026 ($MILLION)
TABLE 50. ASIA-PACIFIC INHALATION ANESTHESIA MARKET, BY APPLICATION, 2018–2026 ($MILLION),
TABLE 51. ASIA-PACIFIC INHALATION ANESTHESIA MARKET, BY END USER, 2018–2026 ($MILLION)
TABLE 52. JAPAN INHALATION ANESTHESIA MARKET, BY PRODUCT, 2018–2026 ($MILLION)
TABLE 53. JAPAN INHALATION ANESTHESIA MARKET, BY APPLICATION, 2018–2026 ($MILLION)
TABLE 54. JAPAN INHALATION ANESTHESIA MARKET, BY END USER, 2018–2026 ($MILLION)
TABLE 55. CHINA INHALATION ANESTHESIA MARKET, BY PRODUCT, 2018–2026 ($MILLION)
TABLE 56. CHINA INHALATION ANESTHESIA MARKET, BY APPLICATION, 2018–2026 ($MILLION)
TABLE 57. CHINA INHALATION ANESTHESIA MARKET, BY END USER, 2018–2026 ($MILLION)
TABLE 58. INDIA INHALATION ANESTHESIA MARKET, BY PRODUCT, 2018–2026 ($MILLION)
TABLE 59. INDIA INHALATION ANESTHESIA MARKET, BY APPLICATION, 2018–2026 ($MILLION)
TABLE 60. INDIA INHALATION ANESTHESIA MARKET, BY END USER, 2018–2026 ($MILLION)
TABLE 61. AUSTRALIA INHALATION ANESTHESIA MARKET, BY PRODUCT, 2018–2026 ($MILLION)
TABLE 62. AUSTRALIA INHALATION ANESTHESIA MARKET, BY APPLICATION, 2018–2026 ($MILLION)
TABLE 63. AUSTRALIA INHALATION ANESTHESIA MARKET, BY END USER, 2018–2026 ($MILLION)
TABLE 64. REST OF ASIA-PACIFIC INHALATION ANESTHESIA MARKET, BY PRODUCT, 2018–2026 ($MILLION)
TABLE 65. REST OF ASIA-PACIFIC INHALATION ANESTHESIA MARKET, BY APPLICATION, 2018–2026 ($MILLION)
TABLE 66. REST OF ASIA-PACIFIC INHALATION ANESTHESIA MARKET, BY END USER, 2018–2026 ($MILLION)
TABLE 67. LAMEA INHALATION ANESTHESIA MARKET, BY COUNTRY, 2018–2026 ($MILLION)
TABLE 68. LAMEA INHALATION ANESTHESIA MARKET, BY PRODUCT, 2018–2026 ($MILLION)
TABLE 69. LAMEA INHALATION ANESTHESIA MARKET, BY APPLICATION, 2018–2026 ($MILLION),
TABLE 70. LAMEA INHALATION ANESTHESIA MARKET, BY END USER, 2018–2026 ($MILLION)
TABLE 71. BRAZIL INHALATION ANESTHESIA MARKET, BY PRODUCT, 2018–2026 ($MILLION)
TABLE 72. BRAZIL INHALATION ANESTHESIA MARKET, BY APPLICATION, 2018–2026 ($MILLION)
TABLE 73. BRAZIL INHALATION ANESTHESIA MARKET, BY END USER, 2018–2026 ($MILLION)
TABLE 74. SAUDI ARABIA INHALATION ANESTHESIA MARKET, BY PRODUCT, 2018–2026 ($MILLION)
TABLE 75. SAUDI ARABIA INHALATION ANESTHESIA MARKET, BY APPLICATION, 2018–2026 ($MILLION)
TABLE 76. SAUDI ARABIA INHALATION ANESTHESIA MARKET, BY END USER, 2018–2026 ($MILLION)
TABLE 77. SOUTH AFRICA INHALATION ANESTHESIA MARKET, BY PRODUCT, 2018–2026 ($MILLION)
TABLE 78. SOUTH AFRICA INHALATION ANESTHESIA MARKET, BY APPLICATION, 2018–2026 ($MILLION)
TABLE 79. SOUTH AFRICA INHALATION ANESTHESIA MARKET, BY END USER, 2018–2026 ($MILLION)
TABLE 80. REST OF LAMEA INHALATION ANESTHESIA MARKET, BY PRODUCT, 2018–2026 ($MILLION)
TABLE 81. REST OF LAMEA INHALATION ANESTHESIA MARKET, BY APPLICATION, 2018–2026 ($MILLION)
TABLE 82. REST OF LAMEA INHALATION ANESTHESIA MARKET, BY END USER, 2018–2026 ($MILLION)
TABLE 83. ABBVIE: COMPANY SNAPSHOT
TABLE 84. ABBVIE: OPERATING BUSINESS SEGMENT
TABLE 85. ABBVIE: PRODUCT PORTFOLIO
TABLE 86. BAXTER: COMPANY SNAPSHOT
TABLE 87. BAXTER: BUSINESS UNITS
TABLE 88. FRESENIUS: COMPANY SNAPSHOT
TABLE 89. FRESENIUS: OPERATING BUSINESS SEGMENTS
TABLE 90. FRESENIUS: PRODUCT PORTFOLIO
TABLE 91. HALOCARBONS: COMPANY SNAPSHOT
TABLE 92. HALOCARBONS: PRODUCT BUSINESS SEGMENT
TABLE 93. HALOCARBONS: PRODUCT PORTFOLIO
TABLE 94. HIKIMA: COMPANY SNAPSHOT
TABLE 95. HIKIMA: OPERATING SEGMENTS
TABLE 96. HIKIMA: PRODUCT PORTFOLIO
TABLE 97. HENGRUI.: COMPANY SNAPSHOT
TABLE 98. HENGRUI.: OPERATING BUSINESS SEGMENTS
TABLE 99. HENGRUI.: PRODUCT PORTFOLIO
TABLE 100. LUNAN: COMPANY SNAPSHOT
TABLE 101. LUNAN: PRODUCT PORTFOLIO
TABLE 102. NOVARTIS: COMPANY SNAPSHOT
TABLE 103. NOVARTIS: OPERATING BUSINESS SEGMENTS
TABLE 104. NOVARTIS: PRODUCT PORTFOLIO
TABLE 105. PIRAMAL: COMPANY SNAPSHOT
TABLE 106. PIRAMAL: OPERATING SEGMENTS
TABLE 107. PIRAMAL: PRODUCT PORTFOLIO
TABLE 108. TROIKAA: COMPANY SNAPSHOT
TABLE 109. TROIKAA: OPERATING SEGMENTS
TABLE 110. TROIKAA: PRODUCT PORTFOLIO
TABLE 01. INHALATION ANESTHESIA MARKET, BY PRODUCT, 2018–2026 ($MILLION)
TABLE 02. INHALATION ANESTHESIA MARKET FOR SEVOFLURANE, BY REGION, 2018–2026 ($MILLION)
TABLE 03. INHALATION ANESTHESIA MARKET FOR DESFLURANE, BY REGION, 2018–2026 ($MILLION)
TABLE 04. INHALATION ANESTHESIA MARKET FOR ISOFLURANE, BY REGION, 2018–2026 ($MILLION)
TABLE 05. INHALATION ANESTHESIA MARKET FOR NITROUS OXIDE, BY REGION, 2018–2026 ($MILLION)
TABLE 06. INHALATION ANESTHESIA MARKET, BY APPLICATION, 2018–2026 ($MILLION)
TABLE 07. INHALATION ANESTHESIA MARKET FOR INDUCTION, BY REGION, 2018–2026 ($MILLION)
TABLE 08. INHALATION ANESTHESIA FOR MAINTENANCES MARKET, BY REGION, 2018–2026 ($MILLION)
TABLE 09. INHALATION ANESTHESIA MARKET, BY END USER, 2018–2026 ($MILLION)
TABLE 10. INHALATION ANESTHESIA MARKET FOR HOSPITALS, BY REGION, 2018–2026 ($MILLION)
TABLE 11. INHALATION ANESTHESIA MAINTENANCES MARKET FOR AMBULATORY SERVICE CENTERS, BY REGION, 2018–2026 ($MILLION)
TABLE 12. INHALATION ANESTHESIA MARKET, BY REGION, 2018–2026 ($MILLION)
TABLE 13. NORTH AMERICA INHALATION ANESTHESIA MARKET, BY COUNTRY, 2018–2026 ($MILLION)
TABLE 14. NORTH AMERICA INHALATION ANESTHESIA MARKET, BY PRODUCT, 2018–2026 ($MILLION)
TABLE 15. NORTH AMERICA INHALATION ANESTHESIA MARKET, BY APPLICATION, 2018–2026 ($MILLION)
TABLE 16. NORTH AMERICA INHALATION ANESTHESIA MARKET, BY END USER, 2018–2026 ($MILLION)
TABLE 17. U.S. INHALATION ANESTHESIA MARKET BY PRODUCT, 2018–2026 ($MILLION)
TABLE 18. U.S. INHALATION ANESTHESIA MARKET BY APPLICATION, 2018–2026 ($MILLION)
TABLE 19. U.S. INHALATION ANESTHESIA MARKET BY END USER, 2018–2026 ($MILLION)
TABLE 20. CANADA INHALATION ANESTHESIA MARKET BY PRODUCT, 2018–2026 ($MILLION)
TABLE 21. CANADA INHALATION ANESTHESIA MARKET BY APPLICATION, 2018–2026 ($MILLION)
TABLE 22. CANADA INHALATION ANESTHESIA MARKET BY END USER, 2018–2026 ($MILLION)
TABLE 23. MEXICO INHALATION ANESTHESIA MARKET, BY PRODUCT, 2018–2026 ($MILLION)
TABLE 24. MEXICO INHALATION ANESTHESIA MARKET, BY APPLICATION, 2018–2026 ($MILLION)
TABLE 25. MEXICO INHALATION ANESTHESIA MARKET, BY END USER, 2018–2026 ($MILLION)
TABLE 26. EUROPE INHALATION ANESTHESIA MARKET, BY COUNTRY, 2018–2026 ($MILLION)
TABLE 27. EUROPE INHALATION ANESTHESIA MARKET, BY PRODUCT, 2018–2026 ($MILLION)
TABLE 28. EUROPE INHALATION ANESTHESIA MARKET, BY APPLICATION, 2018–2026 ($MILLION)
TABLE 29. EUROPE INHALATION ANESTHESIA MARKET, BY END USER, 2018–2026 ($MILLION)
TABLE 30. GERMANY INHALATION ANESTHESIA MARKET, BY PRODUCT, 2018–2026 ($MILLION)
TABLE 31. GERMANY INHALATION ANESTHESIA MARKET, BY APPLICATION, 2018–2026 ($MILLION)
TABLE 32. GERMANY INHALATION ANESTHESIA MARKET, BY END USER, 2018–2026 ($MILLION)
TABLE 33. FRANCE INHALATION ANESTHESIA MARKET, BY PRODUCT, 2018–2026 ($MILLION)
TABLE 34. FRANCE INHALATION ANESTHESIA MARKET, BY APPLICATION, 2018–2026 ($MILLION)
TABLE 35. FRANCE INHALATION ANESTHESIA MARKET, BY END USER, 2018–2026 ($MILLION)
TABLE 36. U.K. INHALATION ANESTHESIA MARKET, BY PRODUCT, 2018–2026 ($MILLION)
TABLE 37. U.K. INHALATION ANESTHESIA MARKET, BY APPLICATION, 2018–2026 ($MILLION)
TABLE 38. U.K. INHALATION ANESTHESIA MARKET, BY END USER, 2018–2026 ($MILLION)
TABLE 39. ITALY INHALATION ANESTHESIA MARKET, BY PRODUCT, 2018–2026 ($MILLION)
TABLE 40. ITALY INHALATION ANESTHESIA MARKET, BY APPLICATION, 2018–2026 ($MILLION)
TABLE 41. ITALY INHALATION ANESTHESIA MARKET, BY END USER, 2018–2026 ($MILLION)
TABLE 42. SPAIN INHALATION ANESTHESIA MARKET, BY PRODUCT, 2018–2026 ($MILLION)
TABLE 43. SPAIN INHALATION ANESTHESIA MARKET, BY APPLICATION, 2018–2026 ($MILLION)
TABLE 44. SPAIN INHALATION ANESTHESIA MARKET, BY END USER, 2018–2026 ($MILLION)
TABLE 45. REST OF EUROPE INHALATION ANESTHESIA MARKET, BY PRODUCT, 2018–2026 ($MILLION)
TABLE 46. REST OF EUROPE INHALATION ANESTHESIA MARKET, BY APPLICATION, 2018–2026 ($MILLION)
TABLE 47. REST OF EUROPE INHALATION ANESTHESIA MARKET, BY END USER, 2018–2026 ($MILLION)
TABLE 48. ASIA-PACIFIC INHALATION ANESTHESIA MARKET, BY COUNTRY, 2018–2026 ($MILLION)
TABLE 49. ASIA-PACIFIC INHALATION ANESTHESIA MARKET, BY PRODUCT, 2018–2026 ($MILLION)
TABLE 50. ASIA-PACIFIC INHALATION ANESTHESIA MARKET, BY APPLICATION, 2018–2026 ($MILLION),
TABLE 51. ASIA-PACIFIC INHALATION ANESTHESIA MARKET, BY END USER, 2018–2026 ($MILLION)
TABLE 52. JAPAN INHALATION ANESTHESIA MARKET, BY PRODUCT, 2018–2026 ($MILLION)
TABLE 53. JAPAN INHALATION ANESTHESIA MARKET, BY APPLICATION, 2018–2026 ($MILLION)
TABLE 54. JAPAN INHALATION ANESTHESIA MARKET, BY END USER, 2018–2026 ($MILLION)
TABLE 55. CHINA INHALATION ANESTHESIA MARKET, BY PRODUCT, 2018–2026 ($MILLION)
TABLE 56. CHINA INHALATION ANESTHESIA MARKET, BY APPLICATION, 2018–2026 ($MILLION)
TABLE 57. CHINA INHALATION ANESTHESIA MARKET, BY END USER, 2018–2026 ($MILLION)
TABLE 58. INDIA INHALATION ANESTHESIA MARKET, BY PRODUCT, 2018–2026 ($MILLION)
TABLE 59. INDIA INHALATION ANESTHESIA MARKET, BY APPLICATION, 2018–2026 ($MILLION)
TABLE 60. INDIA INHALATION ANESTHESIA MARKET, BY END USER, 2018–2026 ($MILLION)
TABLE 61. AUSTRALIA INHALATION ANESTHESIA MARKET, BY PRODUCT, 2018–2026 ($MILLION)
TABLE 62. AUSTRALIA INHALATION ANESTHESIA MARKET, BY APPLICATION, 2018–2026 ($MILLION)
TABLE 63. AUSTRALIA INHALATION ANESTHESIA MARKET, BY END USER, 2018–2026 ($MILLION)
TABLE 64. REST OF ASIA-PACIFIC INHALATION ANESTHESIA MARKET, BY PRODUCT, 2018–2026 ($MILLION)
TABLE 65. REST OF ASIA-PACIFIC INHALATION ANESTHESIA MARKET, BY APPLICATION, 2018–2026 ($MILLION)
TABLE 66. REST OF ASIA-PACIFIC INHALATION ANESTHESIA MARKET, BY END USER, 2018–2026 ($MILLION)
TABLE 67. LAMEA INHALATION ANESTHESIA MARKET, BY COUNTRY, 2018–2026 ($MILLION)
TABLE 68. LAMEA INHALATION ANESTHESIA MARKET, BY PRODUCT, 2018–2026 ($MILLION)
TABLE 69. LAMEA INHALATION ANESTHESIA MARKET, BY APPLICATION, 2018–2026 ($MILLION),
TABLE 70. LAMEA INHALATION ANESTHESIA MARKET, BY END USER, 2018–2026 ($MILLION)
TABLE 71. BRAZIL INHALATION ANESTHESIA MARKET, BY PRODUCT, 2018–2026 ($MILLION)
TABLE 72. BRAZIL INHALATION ANESTHESIA MARKET, BY APPLICATION, 2018–2026 ($MILLION)
TABLE 73. BRAZIL INHALATION ANESTHESIA MARKET, BY END USER, 2018–2026 ($MILLION)
TABLE 74. SAUDI ARABIA INHALATION ANESTHESIA MARKET, BY PRODUCT, 2018–2026 ($MILLION)
TABLE 75. SAUDI ARABIA INHALATION ANESTHESIA MARKET, BY APPLICATION, 2018–2026 ($MILLION)
TABLE 76. SAUDI ARABIA INHALATION ANESTHESIA MARKET, BY END USER, 2018–2026 ($MILLION)
TABLE 77. SOUTH AFRICA INHALATION ANESTHESIA MARKET, BY PRODUCT, 2018–2026 ($MILLION)
TABLE 78. SOUTH AFRICA INHALATION ANESTHESIA MARKET, BY APPLICATION, 2018–2026 ($MILLION)
TABLE 79. SOUTH AFRICA INHALATION ANESTHESIA MARKET, BY END USER, 2018–2026 ($MILLION)
TABLE 80. REST OF LAMEA INHALATION ANESTHESIA MARKET, BY PRODUCT, 2018–2026 ($MILLION)
TABLE 81. REST OF LAMEA INHALATION ANESTHESIA MARKET, BY APPLICATION, 2018–2026 ($MILLION)
TABLE 82. REST OF LAMEA INHALATION ANESTHESIA MARKET, BY END USER, 2018–2026 ($MILLION)
TABLE 83. ABBVIE: COMPANY SNAPSHOT
TABLE 84. ABBVIE: OPERATING BUSINESS SEGMENT
TABLE 85. ABBVIE: PRODUCT PORTFOLIO
TABLE 86. BAXTER: COMPANY SNAPSHOT
TABLE 87. BAXTER: BUSINESS UNITS
TABLE 88. FRESENIUS: COMPANY SNAPSHOT
TABLE 89. FRESENIUS: OPERATING BUSINESS SEGMENTS
TABLE 90. FRESENIUS: PRODUCT PORTFOLIO
TABLE 91. HALOCARBONS: COMPANY SNAPSHOT
TABLE 92. HALOCARBONS: PRODUCT BUSINESS SEGMENT
TABLE 93. HALOCARBONS: PRODUCT PORTFOLIO
TABLE 94. HIKIMA: COMPANY SNAPSHOT
TABLE 95. HIKIMA: OPERATING SEGMENTS
TABLE 96. HIKIMA: PRODUCT PORTFOLIO
TABLE 97. HENGRUI.: COMPANY SNAPSHOT
TABLE 98. HENGRUI.: OPERATING BUSINESS SEGMENTS
TABLE 99. HENGRUI.: PRODUCT PORTFOLIO
TABLE 100. LUNAN: COMPANY SNAPSHOT
TABLE 101. LUNAN: PRODUCT PORTFOLIO
TABLE 102. NOVARTIS: COMPANY SNAPSHOT
TABLE 103. NOVARTIS: OPERATING BUSINESS SEGMENTS
TABLE 104. NOVARTIS: PRODUCT PORTFOLIO
TABLE 105. PIRAMAL: COMPANY SNAPSHOT
TABLE 106. PIRAMAL: OPERATING SEGMENTS
TABLE 107. PIRAMAL: PRODUCT PORTFOLIO
TABLE 108. TROIKAA: COMPANY SNAPSHOT
TABLE 109. TROIKAA: OPERATING SEGMENTS
TABLE 110. TROIKAA: PRODUCT PORTFOLIO
LIST OF FIGURES
FIGURE 01. INHALATION ANESTHESIA, MARKET SEGMENTATION
FIGURE 02. TOP INVESTMENT POCKETS
FIGURE 03. TOP PLAYER POSITIONING
FIGURE 04. DRIVERS, RESTRAINT, AND OPPORTUNITY, INHALATION ANESTHESIA MARKET
FIGURE 05. COMPARATIVE SHARE ANALYSIS OF INHALATION ANESTHESIA MARKET FOR SEVOFLURANE, BY COUNTRY, 2018 & 2026 (%)
FIGURE 06. COMPARATIVE SHARE ANALYSIS OF INHALATION ANESTHESIA MARKET FOR DESFLURANE MARKET, BY COUNTRY, 2018 & 2026 (%)
FIGURE 07. COMPARATIVE SHARE ANALYSIS OF INHALATION ANESTHESIA MARKET FOR ISOFLURANE, BY COUNTRY, 2018 & 2026 (%)
FIGURE 08. COMPARATIVE SHARE ANALYSIS OF INHALATION ANESTHESIA MARKET FOR NITROUS OXIDE, BY COUNTRY, 2018 & 2026 (%)
FIGURE 09. COMPARATIVE SHARE ANALYSIS OF INHALATION ANESTHESIA MARKET FOR INDUCTION, BY COUNTRY, 2018 & 2026 (%)
FIGURE 10. COMPARATIVE SHARE ANALYSIS OF INHALATION ANESTHESIA MARKET FOR MAINTENANCE, BY COUNTRY, 2018 & 2026 (%)
FIGURE 11. COMPARATIVE SHARE ANALYSIS OF INHALATION ANESTHESIA MARKET FOR HOSPITALS, BY COUNTRY, 2018 & 2026 (%)
FIGURE 12. COMPARATIVE SHARE ANALYSIS OF AMBULATORY SERVICE CENTERS MARKET, BY COUNTRY, 2018 & 2026 (%)
FIGURE 13. ABBVIE: NET SALES, 2016–2018 ($MILLION)
FIGURE 14. ABBVIE: REVENUE SHARE, BY REGION, 2018 (%)
FIGURE 15. NET SALES, 2016–2018 ($MILLION)
FIGURE 16. BAXTER: REVENUE SHARE BY BUSINESS UNIT, 2018 (%)
FIGURE 17. BAXTER: REVENUE SHARE, BY REGION, 2018 (%)
FIGURE 18. FRESENIUS: NET SALES, 2016–2018 ($MILLION)
FIGURE 19. FRESENIUS: REVENUE SHARE BY SEGMENT, 2018 (%)
FIGURE 20. FRESENIUS: REVENUE SHARE, BY REGION, 2018 (%)
FIGURE 21. HIKIMA: NET SALES, 2016–2018 ($MILLION)
FIGURE 22. HIKIMA: REVENUE SHARE BY SEGMNET, 2018 (%)
FIGURE 23. HIKIMA: REVENUE SHARE, BY REGION, 2018 (%)
FIGURE 24. NOVARTIS AG: NET SALES, 2016–2018 ($MILLION)
FIGURE 25. NOVARTIS AG: REVENUE SHARE BY SEGMENT, 2018 (%)
FIGURE 26. NOVARTIS AG: REVENUE SHARE BY GEOGRAPHY, 2018 (%)
FIGURE 27. PIRAMAL: NET SALES, 2016–2019 ($MILLION)
FIGURE 28. PIRAMAL: REVENUE SHARE BY SEGMENT, 2019 (%)
FIGURE 01. INHALATION ANESTHESIA, MARKET SEGMENTATION
FIGURE 02. TOP INVESTMENT POCKETS
FIGURE 03. TOP PLAYER POSITIONING
FIGURE 04. DRIVERS, RESTRAINT, AND OPPORTUNITY, INHALATION ANESTHESIA MARKET
FIGURE 05. COMPARATIVE SHARE ANALYSIS OF INHALATION ANESTHESIA MARKET FOR SEVOFLURANE, BY COUNTRY, 2018 & 2026 (%)
FIGURE 06. COMPARATIVE SHARE ANALYSIS OF INHALATION ANESTHESIA MARKET FOR DESFLURANE MARKET, BY COUNTRY, 2018 & 2026 (%)
FIGURE 07. COMPARATIVE SHARE ANALYSIS OF INHALATION ANESTHESIA MARKET FOR ISOFLURANE, BY COUNTRY, 2018 & 2026 (%)
FIGURE 08. COMPARATIVE SHARE ANALYSIS OF INHALATION ANESTHESIA MARKET FOR NITROUS OXIDE, BY COUNTRY, 2018 & 2026 (%)
FIGURE 09. COMPARATIVE SHARE ANALYSIS OF INHALATION ANESTHESIA MARKET FOR INDUCTION, BY COUNTRY, 2018 & 2026 (%)
FIGURE 10. COMPARATIVE SHARE ANALYSIS OF INHALATION ANESTHESIA MARKET FOR MAINTENANCE, BY COUNTRY, 2018 & 2026 (%)
FIGURE 11. COMPARATIVE SHARE ANALYSIS OF INHALATION ANESTHESIA MARKET FOR HOSPITALS, BY COUNTRY, 2018 & 2026 (%)
FIGURE 12. COMPARATIVE SHARE ANALYSIS OF AMBULATORY SERVICE CENTERS MARKET, BY COUNTRY, 2018 & 2026 (%)
FIGURE 13. ABBVIE: NET SALES, 2016–2018 ($MILLION)
FIGURE 14. ABBVIE: REVENUE SHARE, BY REGION, 2018 (%)
FIGURE 15. NET SALES, 2016–2018 ($MILLION)
FIGURE 16. BAXTER: REVENUE SHARE BY BUSINESS UNIT, 2018 (%)
FIGURE 17. BAXTER: REVENUE SHARE, BY REGION, 2018 (%)
FIGURE 18. FRESENIUS: NET SALES, 2016–2018 ($MILLION)
FIGURE 19. FRESENIUS: REVENUE SHARE BY SEGMENT, 2018 (%)
FIGURE 20. FRESENIUS: REVENUE SHARE, BY REGION, 2018 (%)
FIGURE 21. HIKIMA: NET SALES, 2016–2018 ($MILLION)
FIGURE 22. HIKIMA: REVENUE SHARE BY SEGMNET, 2018 (%)
FIGURE 23. HIKIMA: REVENUE SHARE, BY REGION, 2018 (%)
FIGURE 24. NOVARTIS AG: NET SALES, 2016–2018 ($MILLION)
FIGURE 25. NOVARTIS AG: REVENUE SHARE BY SEGMENT, 2018 (%)
FIGURE 26. NOVARTIS AG: REVENUE SHARE BY GEOGRAPHY, 2018 (%)
FIGURE 27. PIRAMAL: NET SALES, 2016–2019 ($MILLION)
FIGURE 28. PIRAMAL: REVENUE SHARE BY SEGMENT, 2019 (%)
